Associations between paraoxonase-1 activity and therapeutic drug monitoring indicators in schizophrenia patients treated with olanzapine: A cross-sectional study

Pharmacology, Toxicology and Pharmaceutical Science

• Cross-Sectional Study 100%
• Olanzapine 100%
• Aryldialkylphosphatase 1 100%
• Therapeutic Drug Monitoring 100%
• Homocysteine 18%
• Metabolic Syndrome X 9%
• Positive Syndrome 9%
• Negative Syndrome 9%
• Triacylglycerol 9%
• High Density Lipoprotein 9%

Biochemistry, Genetics and Molecular Biology

• Cross Sectional Study 100%
• Paraoxonase 100%
• Olanzapine 100%
• Aryldialkylphosphatase 100%
• Metabolite 18%
• Homocysteine 18%
• Triglyceride 9%
• Drug Concentration 9%
• High-Density Lipoprotein 9%